Anixa Biosciences

Anixa Biosciences is an early stage biotechnology company. The company's subsidiary, Anixa Diagnostics Corporation, develop Cchek?, a platform for non-invasive blood tests for the early detection of cancer. The company's Cchek? cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence, and quantity of certain immune cells that exist in and around a tumor and that can be found in the blood stream. The company's other subsidiary, Certainty Therapeutics, Inc., develops immuno-therapy drugs against cancer. The company is also engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.
  • TickerANIX
  • ISINUS03528H1095
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States
Jonathan Moreland

InsiderInsights Daily Ratings Report: June 17, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland

InsiderInsights Daily Ratings Report: June 17, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ResearchPool Subscriptions

Get the most out of your insights

Get in touch